Schedule 13G ownership disclosure
CLEARMIND MEDICINE INC
Common Stock, no par value · CUSIP: 185053501
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iroquois Capital Management, LLC
Shares: 131,886.00 · Class: 8.1%
- Richard Abbe
Shares: 166,464.00 · Class: 9.99%
- Kimberly Page
Shares: 131,886.00 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-26-000424
- Form type
- SCHEDULE 13G/A
- Filer
- Clearmind Medicine Inc.
- CIK
- CIK 1892500
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership